ReviewDrug design, development and therapy2022

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges.

Xuerun Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.